BERGEN COUNTY VACCINATION CENTER NOW OFFERING COVID-19 BOOSTER SHOTS


PARAMUS, NJ – The County of Bergen in partnership with Bergen New Bridge Medical Center announces that starting today, Monday, September 27, the Bergen County Vaccination Center will begin offering booster shots of the Pfizer mRNA COVID-19 vaccine to the following:

· Those over 65

· Long term care facility residents at least six months after they were fully vaccinated

· Healthcare workers, teachers, and other workers at risk

· Those age 50-64 with underlying medical conditions according to the eligibility guidance provided by the ACIP and CDC.

The Bergen County Vaccination Center also continues to offer all three COVID-19 vaccines to those who have yet to receive a first dose. The Pfizer COVID-19 vaccine is available to anyone age 12 or older and the Moderna and Johnson & Johnson/Janssen vaccines are available to anyone age 18 or older. Bergen County health officials strongly urge all who are eligible to receive their vaccines as the more contagious Delta variant is responsible for 99% of COVID cases.

The Bergen County Vaccination Center is located on the campus of Bergen New Bridge Medical Center, 230 E Ridgewood Ave, Paramus, NJ 07652. Vaccinations will be offered Monday through Thursday from 7 a.m. to 3 p.m.

The County Vaccination Center located in Annex 2 (large white tent complex, follow signs) at Bergen New Bridge Medical Center, 230 E. Ridgewood Ave. Paramus, NJ 07652. Monday-Thursday 7am-3pm. For appointment visit BergenCovidVaccine.com. Walk ins welcome. All vaccine recipients must show proof of age, and those ages 12-17 should be accompanied by a parent or legal guardian. Vaccine recipients must live, work or attend school in New Jersey.

Additional Information: Bergen County Executive Jim Tedesco and Bergen New Bridge Medical Center CEO Deborah Visconi are available to speak to the media and media are invited to visit the Vaccination Center today, Monday, September 27.

  • Currently 0.00/5
Rating: 0.00/5 (0 votes cast)

Share It!

Be the first to comment